Uscom Limited (UCM) Is Yet to See Trading Action on Dec 6

December 6, 2017 - By Dolores Ford

Shares of Uscom Limited (ASX:UCM) closed at 0.15 yesterday. Uscom Limited currently has a total float of 112.75M shares and on average sees 44,901 shares exchange hands each day. The stock now has a 52-week low of 0.15 and high of 0.28.

Why More Investors Are Looking Into S&P/ASX 200 Stocks

Australia takes pride with good corporate governance, which is why it is one of Asia’s fastest growing economies today. A nation’s good corporate governance improves its growth potentials as it lures domestic and foreign investors alike to bank on its equity market. CG Watch, which publishes ranks top Asian markets in terms of corporate governance biannually, has included Australia in its recent list.

The Australian Equity Market

Uscom Limited is traded on the The Australian Securities Exchange (ASX) one of the biggest stock exchanges in Asia. And Uscom Limited also included in its list. As of May 2014, over 2,000 companies are listed on the ASX, boasting with a total market capitalization of almost A$2 trillion.

One of the benchmark indices in Australia is the S&P/ASX 200, which tracks as much as 200 most actively traded stocks on the ASX.

The S&P/ASX 200

The S&P/ASX 200 carries on from All Ordinaries, which was formed in January 1980 to serve as the main Australian benchmark index, when it was established in April 2000. It had started at 3,133.30 points.

Continuing from the history of All Ordinaries, the S&P/ASX 200 had hit its all-time low of 1,358.50 points in November 1992. Eventually, it was able to recover, hitting its all-time high of 6,828.70 points during the same month in 2007. In February of that year, the S&P/ASX 200 had first reached the 6,000 mark. Investors had flocked the ASX that time, seeking for safe-haven assets in preparation for the Global Financial Crisis of 2008 amid early signs pointing out to its onslaught. Australia have always boasted with a compelling borrowing environment, which is why investors have always relied to its economy for valuable investment growth.

The S&P/ASX 200 is rebalanced quarterly by a panel of five members, the Index Committee. The review happens on the 16th of every quarter-end month— March, June, September, and December. Up to 200 companies make up the S&P/ASX, depending on their liquidity, market capitalization, and other factors. Uscom Limited liquidity gives it an ability to perform the obligations with ease.

The S&P/ASX 200 is a free-float market-capitalization-weighted index, which means that stocks are evaluated based on their respective market capitalizations with respect to their share prices. Given this, stocks held by venture capitalists and the government are excluded since they are not often traded on the ASX.

When the components of the S&P/ASX 200 were last reviewed on September 16, six stocks had been removed while six new stocks had been included. Roughly 40% of the index is composed of the financial sector.

The S&P/ASX 200 represents about 80% of the total market valuation on the ASX, which is why it is an important indicator of the Australian economy. Similarly, it has a huge impact on the entire Asian economy.

Investors can surely benefit from the low interest rates and a healthy equity market in Australia. Uscom Limited has relatively good liquidity. That being said, investing in ASX stocks is highly recommended for those who are seeking higher near-term and long-term returns alike. Investors prefer the companies like Uscom Limited where they can easily see its liquidity ratio.

More recent Uscom Limited (ASX:UCM) news were published by: Medgadget.com which released: “USCOM Non-Invasive Cardiac Output Monitor” on October 17, 2007. Also Reuters.com published the news titled: “Uscom ‍says Co receives GSA listing to sell to U.S. government​” on November 12, 2017. Reuters.com‘s news article titled: “Uscom announces a distribution agreement with with Pacific Medical Systems” with publication date: July 17, 2017 was also an interesting one.

Uscom Limited designs, develops, manufactures, and markets non-invasive cardiovascular and pulmonary medical devices worldwide. The company has market cap of $16.91 million. The firm offers USCOM 1A, a non-invasive hemodynamic monitor that measures cardiovascular function using Doppler ultrasound; BP+, a supra-systolic oscillometric central blood pressure monitor that measures blood pressure and blood pressure waveforms at the heart, as well as in the arm; and SpiroSonic, a pulmonary function testing device based on multi-path ultrasound technology. It currently has negative earnings. It serves hospitals and other medical care locations through a network of distribution partners.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Twitter Auto Publish Powered By : XYZScripts.com